European pharmacovigilance congress 2024

Day 18- virtual

• Biological basis of adverse with focus on scars
• Inmunological adverse reactions
• Signal detection 
• Risk management 
• Communicating safety information in the digital era 

Day 19 - virtual

• Authorities´assessment of pv informations 
• Real word data & real word evidence 
• Manufacturing & pv interfaces 
  Drug safety in marketing autorization applications
• Evolving landscape of electronic safety data in pv 
• Non-EU pv requirements 

Day 22 – Milan

• Evolving pharmacovigilance strategies 
• Main global and local pv updates 
• Practical experience of applying artificial intelligence in pv 
• Audit & inspections